1,923 results on '"DePinho, Ronald A."'
Search Results
102. Data from A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
103. Data from Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types
104. Supplementary Table 1 from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
105. Supplementary Tables 1 - 4 and Figures 1 - 2 from Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma
106. Supplementary Table 2 from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
107. Supplementary Figure 4 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
108. Supplementary Materials and Methods from Chronic Bile Duct Injury Associated with Fibrotic Matrix Microenvironment Provokes Cholangiocarcinoma in p53-Deficient Mice
109. Data from Neuroplastic Changes Occur Early in the Development of Pancreatic Ductal Adenocarcinoma
110. Supplementary Table 1 from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma
111. Supplementary Table 4 from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
112. Supplementary Figure 6 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
113. Supplementary Figures S1-S4 & Table S1 from Chronic Bile Duct Injury Associated with Fibrotic Matrix Microenvironment Provokes Cholangiocarcinoma in p53-Deficient Mice
114. Supplementary Figures 1-4 from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
115. Supplementary Figure 7 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
116. Supplementary Legends and Figures 1-2 from Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma
117. Supplementary Methods from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
118. supplementary material and method from Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
119. Supplementary Table 3 from Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
120. Supplementary Methods and Materials from Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types
121. Supplementary Figure 1 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
122. Supplementary Figures 1-4 from Direct Transcriptional Activation of Promyelocytic Leukemia Protein by IFN Regulatory Factor 3 Induces the p53-Dependent Growth Inhibition of Cancer Cells
123. Data from Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression
124. Supplementary Figure 5 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
125. Supplementary Table 2 from Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types
126. Supplementary Table 1 from A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
127. Data from Direct Transcriptional Activation of Promyelocytic Leukemia Protein by IFN Regulatory Factor 3 Induces the p53-Dependent Growth Inhibition of Cancer Cells
128. Supplementary Figure 2 from Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression
129. supplementary Figures S1-S10 from Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
130. Legends to Supplementary Figures S1-S4 from Chronic Bile Duct Injury Associated with Fibrotic Matrix Microenvironment Provokes Cholangiocarcinoma in p53-Deficient Mice
131. Supplementary Table 2 from A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
132. Supplementary Figure 3 from Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
133. Supplementary Figures 1-5 from A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
134. Supplementary Figure 1 from Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression
135. Supplementary Figure 2 from Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types
136. Supplementary Information from A Genome-Wide Screen Reveals Functional Gene Clusters in the Cancer Genome and Identifies EphA2 as a Mitogen in Glioblastoma
137. Collateral Lethality: A New Therapeutic Strategy in Oncology
138. Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
139. Effective combinatorial immunotherapy for castration-resistant prostate cancer
140. Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer
141. NAD+ biosynthesis as a collateral lethality target for precision oncology
142. Abstract PR011: Histone demethylase KDM5D drives sex-specific differences in colorectal cancer
143. Abstract IA014: Synthetic essentiality identifies TDO2 as a key target in APC-deficient CRC
144. HDAC2 in Primary Sensory Neurons Constitutively Restrains Chronic Pain by Repressing α2δ-1 Expression and Associated NMDA Receptor Activity
145. Telomerase Extracurricular Activities
146. Foreword
147. Unlimited Mileage from Telomerase?
148. SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2
149. Genetic depletion of de novo coenzyme A biosynthesis exacerbates puromycin toxicity
150. Targeting Cathepsin E in Pancreatic Cancer by a Small Molecule Allows In Vivo Detection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.